Natural Killer Cell (NK-92MI)-Based Therapy for Pulmonary Metastasis of Anaplastic Thyroid Cancer in a Nude Mouse Model-Reference-Cited by-同舟云学术

Natural Killer Cell (NK-92MI)-Based Therapy for Pulmonary Metastasis of Anaplastic Thyroid Cancer in a Nude Mouse Model

Published:2017-07-21 Issue: Volume:8 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Zhu Liya,Li Xiu Juan,Kalimuthu Senthilkumar,Gangadaran Prakash,Lee Ho Won,Oh Ji Min,Baek Se Hwan,Jeong Shin Young,Lee Sang-Woo,Lee Jaetae,Ahn Byeong-Cheol

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference43 articles.

1. Treatment outcome of patients with anaplastic thyroid cancer: a single center experience;Lim;Yonsei Med J,2012

2. Sites of metastases of anaplastic thyroid carcinoma: autopsy findings in 45 cases from a single institution;Besic;Thyroid,2013

3. Potential therapeutic effect of natural killer cells on doxorubicin-resistant breast cancer cells in vitro;Hwang;PLoS One,2015

4. Enhancement of natural killer cell cytotoxicity by sodium/iodide symporter gene-mediated radioiodine pretreatment in breast cancer cells;Kim;PLoS One,2013

5. Evaluation of therapeutic effects of natural killer (NK) cell-based immunotherapy in mice using in vivo apoptosis bioimaging with a caspase-3 sensor;Lee;FASEB J,2014

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging therapeutic options for follicular-derived thyroid cancer in the era of immunotherapy;Frontiers in Immunology;2024-05-29

2. Research progress of immunotherapy against anaplastic thyroid cancer;Frontiers in Oncology;2024-03-26

3. Organic fluorophore-based fluorescent probes for abnormal immune response diagnosis and treatment evaluation;Sensors & Diagnostics;2024

4. An Overview of In Vivo Imaging Techniques;Recent Progress in Pharmaceutical Nanobiotechnology: A Medical Perspective;2023-12-27

5. Remodeled tumor immune microenvironment (TIME) parade via natural killer cells reprogramming in breast cancer;Life Sciences;2023-10